What is the significance of terminating the Rights Agreement early?

The early termination of the Rights Agreement, often referred to as a 'poison pill,' removes a defensive measure that would typically make a hostile takeover more difficult and expensive. For investors, this could signal management's confidence in the company's standalone strategy or potentially open the door for strategic alternatives or acquisition discussions.

How will the declassification of the board affect shareholder influence?

Declassifying the board means that all directors will be up for election annually. This generally increases shareholder influence and accountability, as directors must seek re-election from shareholders each year rather than serving staggered three-year terms. It allows shareholders to more easily express their confidence or lack thereof in the board's performance.

What factors will determine executive bonuses for 2007?

Executive and eligible senior employee bonuses for 2007 will be based on variable compensation awards tied to specific performance criteria. These criteria include profitability, return on net assets, market share, revenue growth, quantitative vital goals, overall business strategy, strategic position, and organizational capability, as determined by the Compensation Committee.

When will the changes to the board structure take effect?

The amendment to the bylaws to declassify the board will be effective immediately prior to the opening of the polls at the 2008 annual meeting of shareholders. Following that meeting, all directors will serve one-year terms.

TER 8-K: Leadership Changes, Material Agreements & More

Summary

Teradyne, Inc. (TER) filed an 8-K report on January 25, 2007, detailing key corporate actions approved by its Board of Directors on January 22, 2007. The most significant event for investors is the early termination of the company's Rights Agreement. The agreement, originally set to expire in November 2010, will now terminate on February 8, 2007. This action effectively removes a poison pill provision, which could signal a shift in the company's strategic approach to potential takeovers or other corporate actions. Additionally, the report outlines the compensation structure for the 2007 fiscal year, specifying performance criteria for variable compensation awards to executive officers and senior employees. The company also announced an amendment to its bylaws to declassify its board of directors, moving from staggered three-year terms to annual elections for all directors, effective prior to the 2008 annual shareholder meeting. These changes collectively impact corporate governance and executive compensation, which are crucial considerations for investors.

Key Highlights

1Early termination of Teradyne's Rights Agreement, with the new expiration date set for February 8, 2007, a significant reduction from the original November 27, 2010 date.
2Approval of specific performance criteria and variable compensation factors for executive and senior employee awards for the 2007 fiscal year under the 2006 Equity and Cash Compensation Incentive Plan.
3Amendment to Teradyne's bylaws to declassify the board of directors, moving from a classified board structure with three-year director terms to an annual election system for all directors.
4The declassification of the board is effective immediately prior to the opening of the polls at the 2008 annual meeting of shareholders.
5All directors elected at the 2008 annual meeting and thereafter will serve one-year terms.
6The company incorporated by reference press releases and amendments to its Rights Agreement and Bylaws as exhibits to this filing.

TERADYNE, INC 8-K Report, Material Agreement (Jan 25, 2007)

Summary

Key Highlights

Frequently Asked Questions